CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment.
Teppert K, Yonezawa Ogusuku IE, Brandes C, Herbel V, Winter N, Werchau N, Khorkova S, Wöhle C, Jelveh N, Bisdorf K, Engels B, Schaser T, Anders K, Künkele A, Lock D.
Teppert K, et al. Among authors: brandes c.
Mol Ther Oncol. 2024 Mar 22;32(2):200797. doi: 10.1016/j.omton.2024.200797. eCollection 2024 Jun 20.
Mol Ther Oncol. 2024.
PMID: 38601972
Free PMC article.